nubeqa
bayer ag - darolutamide - prostatas audzējiem, kastrācija-izturīgs - endokrīnā terapija - nubeqa is indicated for the treatment of adult men with- non metastatic castration resistant prostate cancer (nmcrpc) who are at high risk of developing metastatic disease (see section 5. - metastatic hormone sensitive prostate cancer (mhspc) in combination with docetaxel and androgen deprivation therapy (see section 5.
skin maxfiller (2022.) pulveris
pulveris
dysport 500 v pulveris injekciju šķīduma pagatavošanai
ipsen m.e.p.e., greece - clostridium botulinum a tips, toksīna hemaglutinīna komplekss - pulveris injekciju šķīduma pagatavošanai - 500 v